Natixis Advisors’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$653K Buy
15,031
+15
+0.1% +$652 ﹤0.01% 1419
2025
Q1
$561K Buy
15,016
+238
+2% +$8.89K ﹤0.01% 1431
2024
Q4
$669K Sell
14,778
-190
-1% -$8.6K ﹤0.01% 1406
2024
Q3
$879K Buy
+14,968
New +$879K ﹤0.01% 1333